AI-translated archive post

[Health Chosun] Kim Jino’s Mona Lisa - 6 | The once-in-a-lifetime 고민 for a full life... Hair loss medication: take it or apply it

New Hair Institute · 김진오의 뉴헤어 프로젝트 · November 11, 2025

Minoxidil (*This column was contributed by Dr. Kim Jino, Director of New Hair Plastic Surgery Clinic.) ​ Kim Jino, Director of New Hair Plastic Surgery Clinic (Public Relations Dir...

AI translation notice

This page is an English translation of a Korean Naver Blog archive entry. For exact wording and source context, verify against the Korean archive original and the original Naver post.

Clinic: New Hair Institute

Original post date: November 11, 2025

Translated at: April 25, 2026 at 6:57 AM

Medical note: This translation does not guarantee medical accuracy or suitability for treatment decisions.

[Health Chosun] Kim Jino’s Mona Lisa - 6 | The once-in-a-lifetime 고민 for a full life... Hair loss medication: take it or apply it image 1

[Health Chosun] Kim Jino’s Mona Lisa - 6 | The once-in-a-lifetime 고민 for a full life... Hair loss medication: take it or apply it image 2

Minoxidil

[Health Chosun] Kim Jino’s Mona Lisa - 6 | The once-in-a-lifetime 고민 for a full life... Hair loss medication: take it or apply it image 3

[Health Chosun] Kim Jino’s Mona Lisa - 6 | The once-in-a-lifetime 고민 for a full life... Hair loss medication: take it or apply it image 4

[Health Chosun] Kim Jino’s Mona Lisa - 6 | The once-in-a-lifetime 고민 for a full life... Hair loss medication: take it or apply it image 5

(*This column was contributed by Dr. Kim Jino, Director of New Hair Plastic Surgery Clinic.)

Kim Jino, Director of New Hair Plastic Surgery Clinic (Public Relations Director of the Korean Society of Plastic and Reconstructive Surgeons · Chief Hair Loss Subcommittee Chair of the Korean Society for Laser, Dermatology and Hair)

Original source: Health Chosun

Continue browsing

Keep exploring this clinic's public source trail

Return to the source archive for more translated posts, or open the Korean clinic profile to compare other public channels.